Resumo
Sudden cardiac death (SCD) has emerged as one of the most serious—and most preventable—outcomes in competitive bodybuilding, with an estimated incidence of 32.83 per 100,000 athlete-years among active competitors and a risk more than five times higher in professionals than in amateurs. Speckle-tracking (strain) imaging studies show that athletes exposed to anabolic-androgenic steroids (AAS) have reduced myocardial deformation (a less negative global longitudinal strain, or GLS), often with a preserved ejection fraction—a pattern of subclinical dysfunction that conventional echocardiography misses. This article has two complementary aims: (1) to synthesize the scientific evidence supporting strain echocardiography as a cardiovascular surveillance tool in this population; and (2) to present an operational proposal—a Structured Cardiovascular Surveillance Protocol (SCSP)—that turns this evidence into a practical, replicable routine, bringing federations, coaches, athletes, and partner cardiology services together around an annual screening schedule, without any of these parties taking on the role of deciding for the athlete. The protocol is built on ongoing education, partnerships between events and health care providers to expand access to testing, and a color-coded (traffic-light) risk classification system that communicates results clearly while protecting medical confidentiality and athlete autonomy. We argue that pairing robust clinical evidence with a simple, ethical, and scalable institutional design offers a concrete path toward reducing fatal cardiac events in the sport.
Referências
ALIZADE, E. et al. Comparison of right ventricle systolic function between long-term anabolic-androgenic steroid user and nonuser bodybuilder athletes: a two-dimensional speckle tracking study. Echocardiography, v. 33, n. 8, p. 1178-1185, 2016.
AL-KHATIB, S. M. et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. Circulation, v. 138, n. 13, p. e210-e271, 2018.
ANGELL, P. J. et al. Anabolic steroid use and longitudinal, radial, and circumferential cardiac motion. Medicine and Science in Sports and Exercise, v. 44, n. 4, p. 583-590, 2012.
BAGGISH, A. L. et al. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circulation, v. 135, n. 21, p. 1991-2002, 2017.
CASTRO, R. R. T. D. et al. Subclinical systolic dysfunction in anabolic-androgenic steroid users assessed by speckle-tracking echocardiography. International Journal of Cardiovascular Sciences, v. 38, e20240076, 2025.
CAZORLA, O. et al. Specific alterations of regional myocardial work in strength-trained athletes using anabolic androgenic steroids compared to athletes with genetic hypertrophic cardiomyopathy. Journal of Sport and Health Science, v. 12, n. 3, p. 278-289, 2023.
CORRADO, D. et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA, v. 296, n. 13, p. 1593-1601, 2006.
D'ANDREA, A. et al. Biventricular dysfunction and lung congestion in athletes on anabolic androgenic steroids: a speckle-tracking and stress lung echocardiography analysis. European Journal of Preventive Cardiology, v. 28, n. 17, p. 1928-1938, 2022.
FARSALINOS, K. E. et al. Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE Inter-Vendor Comparison Study. Journal of the American Society of Echocardiography, v. 28, n. 10, p. 1171-1181.e2, 2015.
HAMMOUD, S. et al. Chronic anabolic androgenic steroid administration reduces global longitudinal strain among off-cycle bodybuilders. International Journal of Cardiology, v. 381, p. 153-160, 2023a.
HAMMOUD, S. et al. The association between supraphysiological anabolic-androgenic steroid use and cardiac structure and function through echocardiography. Journal of Science and Medicine in Sport, v. 26, n. 7, p. 625-630, 2023b.
HARMON, K. G. et al. Incidence of sudden cardiac death in National Collegiate Athletic Association athletes. Circulation, v. 123, n. 15, p. 1594-1600, 2011.
LANG, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, v. 28, n. 1, p. 1-39.e14, 2015.
PELLICCIA, A. et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. European Heart Journal, v. 42, n. 1, p. 17-96, 2021.
SMOLIGA, J. M.; WILBER, Z. T.; ROBINSON, B. T. Premature death in bodybuilders: what do we know? Sports Medicine, v. 53, n. 5, p. 933-948, 2023.
SZAUDER, I.; KOVÁCS, A.; PAVLIK, G. Comparison of left ventricular mechanics in runners versus bodybuilders using speckle tracking echocardiography. Cardiovascular Ultrasound, v. 13, art. 7, 2015.
VECCHIATO, M. et al. Mortality in male bodybuilding athletes. European Heart Journal, v. 46, n. 30, p. 3006-3016, 2025.
WORLD MEDICAL ASSOCIATION. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA, v. 310, n. 20, p. 2191-2194, 2013.

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Direitos autorais (c) 2026 Marcos Paulo Nonato de Almeida
